FDA looks to overhaul Orange Book, seeks input on patent listings

FDA looks to overhaul Orange Book, seeks input on patent listings

Source: 
RAPS.org
snippet: 

Nearly 40 years after its creation, the US Food and Drug Administration (FDA) is looking to modernize its Orange Book, which lists patent, exclusivity and therapeutic equivalence information for approved drugs, as part of its effort to increase drug competition.